FFCP PHASE1:Mm9::chr13:21068149..21068151,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=23|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr13:21068149..21068151,-|id=chr13:21068149..21068151,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0001264!9.27e-59!12;UBERON:0003922!9.27e-59!12;UBERON:0002114!9.27e-59!12;UBERON:0003923!9.27e-59!12;UBERON:0003924!9.27e-59!12;UBERON:0003921!9.27e-59!12;UBERON:0001045!3.12e-54!13;UBERON:0002108!4.87e-44!16;UBERON:0002075!4.67e-37!19;UBERON:0000160!5.82e-20!43;UBERON:0002323!6.86e-19!37;UBERON:0004458!6.86e-19!37;UBERON:0003886!2.20e-18!38;UBERON:0002553!6.67e-18!39;UBERON:0005409!1.96e-14!59;UBERON:0000464!4.10e-12!57;UBERON:0000949!1.75e-09!72;UBERON:0000466!1.36e-08!79;UBERON:0005177!6.05e-08!85;UBERON:0001041!2.71e-07!92;UBERON:0000077!6.95e-07!97;UBERON:0002100!8.29e-07!98|ontology_enrichment_uberon_v019_2=UBERON:0001264,1.21e-29,12;UBERON:0002075,4.22e-19,19;UBERON:0002323,3.04e-10,37;UBERON:0004458,3.04e-10,37;UBERON:0003886,5.38e-10,38;UBERON:0002553,9.26e-10,39|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255457055208591,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.30980553359851,0,0,0.943025398779491,0,0.307435147943927,0.775284879504663,0.363533729477506,1.06949213515416,0.948110273807448,7.37930260024991,12.3762651897824,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr13:21068149..21068151,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=23 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:21068149..21068151,- | |||
|description=CAGE_peak_at_chr13:21068149..21068151,- | |||
|id=chr13:21068149..21068151,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0001264!9.27e-59!12;UBERON:0003922!9.27e-59!12;UBERON:0002114!9.27e-59!12;UBERON:0003923!9.27e-59!12;UBERON:0003924!9.27e-59!12;UBERON:0003921!9.27e-59!12;UBERON:0001045!3.12e-54!13;UBERON:0002108!4.87e-44!16;UBERON:0002075!4.67e-37!19;UBERON:0000160!5.82e-20!43;UBERON:0002323!6.86e-19!37;UBERON:0004458!6.86e-19!37;UBERON:0003886!2.20e-18!38;UBERON:0002553!6.67e-18!39;UBERON:0005409!1.96e-14!59;UBERON:0000464!4.10e-12!57;UBERON:0000949!1.75e-09!72;UBERON:0000466!1.36e-08!79;UBERON:0005177!6.05e-08!85;UBERON:0001041!2.71e-07!92;UBERON:0000077!6.95e-07!97;UBERON:0002100!8.29e-07!98 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001264,1.21e-29,12;UBERON:0002075,4.22e-19,19;UBERON:0002323,3.04e-10,37;UBERON:0004458,3.04e-10,37;UBERON:0003886,5.38e-10,38;UBERON:0002553,9.26e-10,39 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255457055208591,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.30980553359851,0,0,0.943025398779491,0,0.307435147943927,0.775284879504663,0.363533729477506,1.06949213515416,0.948110273807448,7.37930260024991,12.3762651897824,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr13:21068149..21068151,- | |||
}} |
Latest revision as of 18:32, 5 August 2015
Short description: | p@chr13:21068149..21068151, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr13:21068149..21068151, - |
Coexpression cluster: | MCL_coexpression_mm9:23 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
pancreas | 1.21e-29 | 12 |
viscus | 4.22e-19 | 19 |
body cavity | 3.04e-10 | 37 |
body cavity or lining | 3.04e-10 | 37 |
body cavity precursor | 5.38e-10 | 38 |
anatomical cavity | 9.26e-10 | 39 |